In this captivating discussion, Alifiya Khan, a health and education reporter at The Ken, dives into her personal quest for weight loss using Ozempic, despite its unapproved status in India. She shares her struggles with obesity and how social media's buzz around the drug has influenced many, including herself. The conversation touches on the controversial nature of Ozempic as a treatment versus a trendy weight-loss solution and the risks involved in procuring it from online sources. Alifiya’s journey highlights the deep, personal ramifications of the evolving obesity landscape.
